Image credit: Jeremy Buckingham

Advil-Maker GlaxoSmithKline Among Entities Newly Lobbying on Cannabis

From CBD and banking legislation in Congress to the right to advertise in legal states, here are the entities newly lobbying on cannabis-related issues at the national level.

Lobbying
Newsletter

NY Senators use Dormitory Authority hearing to seek answers on troubled equity fund • & more …

An excerpt from recent editions of the Cannabis Wire Daily newsletter.

Regulation

Pres. Biden Formally Announces DOJ Will Move to Reclassify Cannabis

Now, the public will have a chance to weigh in on cannabis rescheduling.